Medscape | Roche's Subcutaneous MabThera Approved in Europe Medscape ZURICH (Reuters) - Swiss drugmaker Roche said on Friday that European regulators have approved a new timesaving formulation of its blood cancer drug MabThera (rituximab), which it hopes will help extend the medicine's shelf life. The European ... |
